Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nkarta, Inc. Opens Enrollment for Ntrust-2 Trial Evaluating NKX019 in Multiple Autoimmune Diseases Quiver Quantitative, Inc. - Thu Dec 5, 3:12PM CST

Nkarta opens Ntrust-2 trial for NKX019 in systemic sclerosis, myositis, and vasculitis; myasthenia gravis trial also initiated.Quiver AI SummaryNkarta, Inc. has announced the opening of patient enrollment...

NKTX : 2.37 (+7.73%)
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 GlobeNewswire - Thu Dec 5, 5:01AM CST

NKTX : 2.37 (+7.73%)
Nkarta to Participate in an Upcoming Investor Conference GlobeNewswire - Tue Nov 26, 6:02AM CST

NKTX : 2.37 (+7.73%)
Nkarta to Participate in an Upcoming Investor Conference GlobeNewswire - Tue Nov 12, 7:02AM CST

NKTX : 2.37 (+7.73%)
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights GlobeNewswire - Thu Nov 7, 3:02PM CST

NKTX : 2.37 (+7.73%)
Why Nkarta Stock Is Soaring Today Motley Fool - Wed Aug 14, 11:37AM CDT

One analyst is now more bullish about this clinical-stage biotech stock.

RJF : 155.05 (+2.78%)
NKTX : 2.37 (+7.73%)
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 FinancialNewsMedia - Tue Jan 9, 9:25AM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
AMGN : 263.38 (+0.84%)
AMAM : 28.00 (+0.07%)
ELEV : 0.5800 (-7.30%)
NKTX : 2.37 (+7.73%)
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis PR Newswire - Tue Oct 17, 2023

/PRNewswire/ -- Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced a partnership with Nkarta, Inc. (Nasdaq:...

NKTX : 2.37 (+7.73%)
Why Shares of Nkarta Are Slumping Tuesday Motley Fool - Tue Jun 27, 2023

The pharmaceutical stock dropped after announcing so-so clinical trial results.

CRSP : 40.72 (+0.83%)
NKTX : 2.37 (+7.73%)
Nkarta Announces Key Senior Leadership Team Appointments Globe Newswire - Mon Jul 25, 2022

Ralph Brandenberger, PhD, promoted to Chief Technical OfficerYvonne Li, MBA, promoted to Chief Administrative OfficerEvolution of Nkarta leadership team to...

NKTX : 2.37 (+7.73%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot